AI Detects Breast Cancer Too Small for Human Eye | BBC News

Artificial intelligence is demonstrating the potential to significantly improve breast cancer detection rates, identifying tumors too small for conventional methods. A new study led by the University of Aberdeen in Scotland found that AI tools can increase detection rates by over 10%, offering hope for earlier diagnosis and treatment.

The research, conducted as part of a project within the National Health Service (NHS), evaluated the use of AI software to assist healthcare professionals in analyzing routine mammograms of over 10,000 women. The goal was to determine if AI could expedite results and improve the accuracy of identifying potential cancers.

Yvonne Cook, a 60-year-old resident of Aberdeen, participated in the AI-driven research and was diagnosed with breast cancer thanks to the technology. “I feel incredibly lucky,” Cook stated, highlighting the potential life-saving impact of AI in early cancer detection.

AI Tool, Named Mia, Detects Subtle Anomalies

The AI tool used in the study, called Mia, was developed by the medical technology company Kheiron. Mia is designed to identify small and subtle areas within mammograms that might be missed by the human eye. This capability is crucial, as early detection is often linked to more successful treatment outcomes.

The findings, published in the journal Nature Cancer, revealed a 10.4% increase in detection rates when Mia was used in conjunction with standard mammography practices. This improvement suggests that AI could play a vital role in reducing the number of missed diagnoses and improving patient survival rates.

Expanding the Trial Across the UK

Following the promising results from the initial study, the research team is expanding the trial to include more centers across the United Kingdom. This larger-scale evaluation will assess the effectiveness of AI-assisted mammography in a broader range of clinical settings and patient populations.

The expansion aims to validate the initial findings and gather further data on the benefits and challenges of integrating AI into routine breast cancer screening programs. If successful, the widespread adoption of AI tools like Mia could revolutionize breast cancer detection and significantly improve outcomes for women across the UK.

AI and Cancer Detection: A Growing Field

The University of Aberdeen study is part of a growing body of research exploring the potential of AI in cancer diagnosis. A separate study from Harvard Medical School, published in December 2025, highlighted both the promise and potential pitfalls of using AI in pathology. While AI can accurately identify cancer in tissue samples, researchers found that these systems can also inadvertently infer patient demographics from the slides, potentially leading to biased results for certain groups.

The Harvard study pinpointed three key reasons for this bias and developed a new approach to significantly reduce these disparities. This research underscores the importance of carefully evaluating medical AI for bias to ensure fair and reliable cancer care for all patients.

The ability of AI to analyze complex medical images and identify subtle patterns is transforming the field of cancer diagnostics. However, it’s crucial to address potential biases and ensure that these tools are used responsibly and equitably.

Implications for the Future of Breast Cancer Screening

The integration of AI into breast cancer screening programs has the potential to alleviate the workload on radiologists, reduce diagnostic errors and improve the overall efficiency of healthcare systems. By assisting healthcare professionals in identifying potential cancers at an earlier stage, AI can contribute to more timely and effective treatment interventions.

However, AI is not intended to replace human expertise. Rather, it is designed to augment the skills of healthcare professionals and provide them with additional tools to improve patient care. The successful implementation of AI in breast cancer screening will require careful planning, ongoing evaluation, and a commitment to addressing potential challenges.

As AI technology continues to evolve, it is likely to play an increasingly important role in the fight against cancer. Ongoing research and development efforts are focused on improving the accuracy, reliability, and accessibility of AI-powered diagnostic tools, paving the way for a future where cancer is detected earlier and treated more effectively.